FATAL DIFFUSE ALVEOLAR INJURY FOLLOWING USE OF INTRAPLEURAL BLEOMYCIN

被引:11
作者
AUDU, PBD
SING, RF
METTE, SA
FALLAHNEJHAD, M
机构
关键词
D O I
10.1378/chest.103.5.1638a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1638 / 1638
页数:1
相关论文
共 7 条
[1]  
ALBERTS D, 1978, BLEOMYCIN CURRENT ST, P131
[2]  
ALBERTS DS, 1979, CANCER CHEMOTH PHARM, V2, P127
[3]  
CROOKE ST, 1977, CANCER TREAT REP, V61, P1631
[4]   FACTORS INFLUENCING POST-OPERATIVE MORBIDITY AND MORTALITY IN PATIENTS TREATED WITH BLEOMYCIN [J].
GOLDINER, PL ;
CARLON, GC ;
CVITKOVIC, E ;
SCHWEIZER, O ;
HOWLAND, WS .
BRITISH MEDICAL JOURNAL, 1978, 1 (6128) :1664-1667
[5]  
PALADINE W, 1976, CANCER, V38, P1903, DOI 10.1002/1097-0142(197611)38:5<1903::AID-CNCR2820380506>3.0.CO
[6]  
2-A
[7]   SYSTEMIC TOXICITY FOLLOWING INTRACAVITARY ADMINISTRATION OF BLEOMYCIN [J].
SIEGEL, RD ;
SCHIFFMAN, FJ .
CHEST, 1990, 98 (02) :507-507